← Evidence map

ArticleBlood advances2017

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs.

Silvia Maifrede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29296788